Seer Receives An Unsolicited, Non-Binding Proposal From Omid Farokhzad, M.D., Seer’s Chair And Chief Executive Officer, To Acquire All Of Th
Seer, Inc. (NASDAQ: SEER ), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it has received an unsolicited, non-binding proposal from Omid Farokhzad, M.D., Seer’s Chair and Chief Executive Officer, to acquire all of the outstanding shares of Seer’s Class A common stock for $2